389 related articles for article (PubMed ID: 27357616)
1. Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.
Moss JW; Ramji DP
Future Med Chem; 2016 Jul; 8(11):1317-30. PubMed ID: 27357616
[TBL] [Abstract][Full Text] [Related]
2. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?
Hansen PR
Curr Pharm Des; 2018; 24(3):281-290. PubMed ID: 29318966
[TBL] [Abstract][Full Text] [Related]
3. Nutraceuticals as therapeutic agents for atherosclerosis.
Moss JWE; Williams JO; Ramji DP
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1562-1572. PubMed ID: 29454074
[TBL] [Abstract][Full Text] [Related]
4. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
5. Functional diversity of macrophages in vascular biology and disease.
Park I; Kassiteridi C; Monaco C
Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
[TBL] [Abstract][Full Text] [Related]
6. Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
Hao D; Danbin W; Maojuan G; Chun S; Bin L; Lin Y; Yingxin S; Guanwei F; Yefei C; Qing G; Xijuan J
Pharmacol Res; 2019 Aug; 146():104306. PubMed ID: 31181336
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for cardiovascular disease.
Lutgens E; Atzler D; Döring Y; Duchene J; Steffens S; Weber C
Eur Heart J; 2019 Dec; 40(48):3937-3946. PubMed ID: 31121017
[TBL] [Abstract][Full Text] [Related]
8. Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Muhammad K; Ayoub MA; Iratni R
Curr Pharm Des; 2021; 27(18):2141-2150. PubMed ID: 33461451
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory therapy in atherosclerosis.
Kocyigit D; Gurses KM; Tokgozoglu L
Front Biosci (Landmark Ed); 2020 Jan; 25(2):242-269. PubMed ID: 31585888
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Circuits in Cardiovascular Disease.
Williams JW; Huang LH; Randolph GJ
Immunity; 2019 Apr; 50(4):941-954. PubMed ID: 30995508
[TBL] [Abstract][Full Text] [Related]
11. n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.
Torrejon C; Jung UJ; Deckelbaum RJ
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):319-26. PubMed ID: 18060753
[TBL] [Abstract][Full Text] [Related]
12. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.
Arida A; Protogerou AD; Kitas GD; Sfikakis PP
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954107
[TBL] [Abstract][Full Text] [Related]
13. The role of interferon-γ in cardiovascular disease: an update.
Elyasi A; Voloshyna I; Ahmed S; Kasselman LJ; Behbodikhah J; De Leon J; Reiss AB
Inflamm Res; 2020 Oct; 69(10):975-988. PubMed ID: 32699989
[TBL] [Abstract][Full Text] [Related]
14. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
15. The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis.
Buckley ML; Ramji DP
Biochim Biophys Acta; 2015 Jul; 1852(7):1498-510. PubMed ID: 25887161
[TBL] [Abstract][Full Text] [Related]
16. Nutraceutical therapies for atherosclerosis.
Moss JW; Ramji DP
Nat Rev Cardiol; 2016 Sep; 13(9):513-32. PubMed ID: 27383080
[TBL] [Abstract][Full Text] [Related]
17. Emerging Anti-Atherosclerotic Therapies.
Gluba-Brzózka A; Franczyk B; Rysz-Górzyńska M; Ławiński J; Rysz J
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829992
[TBL] [Abstract][Full Text] [Related]
18. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
Baumgartner R; Forteza MJ; Ketelhuth DFJ
Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
[TBL] [Abstract][Full Text] [Related]
19. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
Front Immunol; 2018; 9():706. PubMed ID: 29719532
[TBL] [Abstract][Full Text] [Related]
20. Chemokines as Therapeutic Targets in Cardiovascular Disease.
Noels H; Weber C; Koenen RR
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):583-592. PubMed ID: 30760014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
